Related Experiment Video
Updated: Aug 8, 2026
IP-FCM: Immunoprecipitation Detected by Flow Cytometry
Published on: December 2, 2010
Flow cytometric quantitation of immunofluorescence intensity: problems and perspectives. European Working Group on
J W Gratama1, J L D'hautcourt, F Mandy
1Department of Clinical and Tumor Immunology, Daniel den Hoed Kliniek, Rotterdam, The Netherlands. gratama@immh.azr.nl
Insights
Quantifying immunofluorescence intensity is crucial for estimating molecule counts on cells, with applications in diagnosing leukemia and monitoring T-cell activation. This review covers methods for accurate fluorescence quantitation and standardization challenges.
Area of Science:
- Immunology
- Cell Biology
- Clinical Diagnostics
Background:
- Quantitation of immunofluorescence intensity is vital for estimating molecule expression on cells.
- Clinical applications are expanding, including antigen detection in leukemia/lymphoma and monitoring T-cell activation (CD38) and platelet activation (CD62P).
Purpose of the Study:
- To discuss quality-control measures for fluorescence intensity quantitation.
- To review seven concepts developed over 15 years for quantifying fluorescence intensity.
- To identify issues hindering standardization of quantitative immunofluorescence assessments.
Main Methods:
- Review of historical and recent methods for fluorescence intensity quantitation.
- Discussion of calibration beads, molecules of equivalent soluble fluorochrome (MESF), and antibody-binding capacity standards.
- Evaluation of different calibration approaches including antibody-binding standards and Ag-specific calibration systems.
Main Results:
- Early methods converted logarithmic channel numbers to relative fluorescence units.
- Calibration beads enabled instrument-independent fluorescence measurement (MESF) and antibody binding per cell quantification.
- Inaccuracies were observed with certain calibrators, potentially due to differences in antibody binding (Fab vs. Fc mediated).
Conclusions:
- Standardization of quantitative immunofluorescence requires addressing issues in instrumentation, reagents, and cell preparation.
- Various calibration strategies exist, but inconsistencies highlight the need for robust quality control.
- Further development is needed for reliable and reproducible quantitative immunofluorescence assays in clinical settings.
Abstract:
Quantitation of immunofluorescence intensity serves to estimate the number of defined molecules expressed on or in cells. Clinical applications of this diagnostic tool are increasing, e.g., aberrant expression of various antigens (Ag) by leukemic blasts or lymphoma cells, intensity of CD38 expression by CD8+ T-lymphocytes to monitor activation status, and intensity of CD62P to detect platelet activation. In this report we discuss the quality-control measures required for quantitation of fluorescence intensity, and we review seven concepts that have been developed to quantify fluorescence intensity during the past 15 years. Initial work addressed the conversion of logarithmic channel numbers into units of relative fluorescence. The design and use of calibration beads labeled with predefined amounts of dye allowed instrument-independent expression of fluorescence intensity in units of molecules of equivalent soluble fluorochrome (MESF). This method was refined by the combined use of such standards with monoclonal antibodies (mAb) conjugated 1:1 with phycoerythrin (PE), allowing translation of fluorescence intensity into numbers of antibodies bound per cell. Alternatively, the use of 1:1 PE-conjugated mAb under the assumption that CD4+ lymphocytes reproducibly bind 50,000 CD4 mAb molecules was proposed to convert units of relative fluorescence intensity into units of antibodies bound per cell. The use of antibody-binding capacity as a surrogate marker for quantification of Ag expression was addressed more directly by the development of antibody-binding standards. The quantitative indirect immunofluorescence assay is based on beads labeled with various amounts of CD5 mAb that calibrate the binding of the secondary antibody in units of antibody-binding capacity. Alternatively, goat anti-mouse-labeled calibration beads have been developed. Published results obtained with the latter calibrators showed an unexpected inaccuracy. The different ways in which calibrators and cells under study bind mAb (i.e., Fab mediated versus Fc mediated) may have contributed to this variation. Recently, the use of stabilized cell populations expressing Ag in a specified range of concentrations has been proposed as an Ag-specific calibration system of mAb binding. We identify several issues on the level of instrumentation, reagents, and cells under study that should be solved to allow standardization of quantitative assessments of immunofluorescence intensity.
